Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Background: Despite advances in circulating tumor DNA analysis, reliable detection of oncological disease from ultra-low coverage whole genome sequencing (ulcWGS) remains challenging, particularly at low tumor fractions. This study leverages cell-free DNA (cfDNA) characteristics to develop and evaluate a robust, integrative binary predictive model for ovarian cancer (OC) status screening. OC repr...
Abstract Background: Acute Lymphoblastic Leukemia (ALL) is a highly heterogeneous pediatric malignancy. Despite high survival rates, relapse and the involvement of central nervous system (CNS) remains a significant clinical challenge. Traditional clinical parameters often lack the precision required for early detection and risk stratification. This study utilizes high-throughput proteomics and mac...
Background and Aims: Endoscopic artificial intelligence is commonly validated on selected single images, whereas gastric cancer interpretation require...
Objective: To develop and evaluate an Observational Medical Outcomes Partnership (OMOP) standardized prostate cancer database from the University of T...
Purpose: To implement a comprehensive knowledge-based algorithm (KBA) for pancreatic cancer staging based on the current Japanese guidelines and to ev...
Predicting metabolite concentrations from gene expression is instrumental for linking regulatory programs to metabolic phenotypes. Prior approaches re...
Advancements in immunogenomics and immuno-oncology have enabled the development of personalized cancer vaccines (PCVs) that target cancer cell-specifi...
Medical practice is bottlenecked by the slow production of high-quality clinical evidence. Despite progress in automating selected stages, autonomous ...
Chromosomal copy number alterations (CNAs) are key drivers of tumor evolution, disease progression and therapeutic resistance, and the identification ...
The early detection of breast cancer currently relies on expensive mammography, followed by pathology that uses biopsied, fixed, and immunohistochemic...
In vivo CAR-T cell therapy eliminates manufacturing complexities associated with ex vivo autologous approaches, but safety concerns have limited adopt...
Background: Heart failure (HF) and chronic obstructive pulmonary disease (COPD) are among the leading causes of morbidity and mortality globally, with...
Huntington's disease (HD) presents a heterogeneous neurodegenerative course, with motor, cognitive, and functional symptoms progressing differently ac...
Chemotherapy-induced peripheral neuropathy (CIPN) is a common and painful side effect of paclitaxel (PTX) treatment. The most common measures of painf...
Micro-ultrasound ($μ$US) is a new, emerging, and promising imaging modality for prostate cancer (PCa) detection, but accurate identification of suspic...
Cancer registries enable cancer surveillance at the population level. These registries require significant human-time to read through many different p...
Abstract. Colorectal cancer (CRC) is challenging to track because its molecular changes are very complex as the disease progresses, creating significa...
Multimodal Large Models have significantly advanced automated breast ultrasound diagnosis. However, most existing frameworks utilize opaque, end-to-en...
Enhancer-derived RNAs (eRNAs) are critical regulators of gene transcription, yet their genome-wide annotation remains challenging. Here, we present eR...
Gastric-type adenocarcinoma of the uterine cervix (GAS) is a rare, aggressive cervical cancer unrelated to HPV infection that is frequently misdiagnos...